Trial Profile
Gemfibrozil + repaglinide in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Aug 2011
Price :
$35
*
At a glance
- Drugs Repaglinide (Primary) ; Gemfibrozil
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Pharmacogenomic; Pharmacokinetics
- 21 Jul 2011 Results published in Drug Metabolism and Disposition.
- 14 Jul 2011 New trial record
- 29 Jun 2011 Results presented at the 10th Congress of the European Association for Clinical Pharmacology and Therapeutics.